PerpEquitiesTop analysts on stock perps · Analyst
Stephen Willey (Stifel Nicolaus): analyst track record on stock perps
Stephen Willey of Stifel Nicolaus on companies with stock perpetual futures: star rating, success rate, price-target accuracy, current calls and the measured perp reaction after each rating.
Stars4.6★
Success48%
Excess return+12.1%
rank#894
Ratings486
ratings on stock perps11
Track record
TipRanks data via FMP| 12 months | 3 years | |
|---|---|---|
| Ratings | 123 | 299 |
| Stock | 27 | 33 |
| Buy / hold / sell | 108 / 15 / 0 | 233 / 66 / 0 |
| Upgrades / downgrades / initiations | 1 / 0 / 4 | 2 / 3 / 11 |
| Price targets hit / missed | 22 / 94 (19%) | 86 / 200 (30%) |
| Avg. return after a rating (TipRanks) | -31.5% | -9.4% |
| Best / worst call | +49.4% / -82.9% | +600.0% / -97.7% |
After buy calls: median 21-day move +4.8% · vs S&P 500 -0.4% · targets hit within a year 17% (n = 11)
Current calls on stock perps
| Stock | Call | Target | vs last close | Date |
|---|---|---|---|---|
| $ABCL AbCellera Biologics Inc. | Buy · Maintained | $9.00 | -14.0% | Aug 6, 2026 |
Recent ratings
- Aug 6, 2026 $ABCL: Maintained · Buy · $9.00 · article
- May 12, 2026 $ABCL: Reiterated · Buy · $8.00 · article
- Apr 30, 2026 $ABCL: Maintained · Buy · $7.00 · article
- Feb 25, 2026 $ABCL: Reiterated · Buy · $7.00 · article
- Nov 7, 2025 $ABCL: Maintained · Buy · $7.00 · article
- Aug 8, 2025 $ABCL: Maintained · Buy · $7.00 · article
- May 9, 2025 $ABCL: Maintained · Buy · $8.00 · article
- Feb 28, 2025 $ABCL: Maintained · Buy · $10.00 · article
- Nov 5, 2024 $ABCL: Maintained · Buy · $12.00 · article
- Aug 7, 2024 $ABCL: Maintained · Buy · $14.00 · article
- Feb 21, 2024 $ABCL: Maintained · Buy · $17.00 · article
Stephen Willey4.6★ · 48% success · +12.1% excess return · TipRanks data via FMP · Source headlines via TheFly/StreetInsider (FMP). Reaction = venue-median perp move after our detection — an observation, not investment advice.